On March 19, 2020, the FDA granted an Emergency Use Authorization (EUA) to Abbott Laboratories for testing on Abbott's m2000 system. The FDA had previously granted similar clearance to Hologic, LabCorp and Thermo Fisher Scientific.
Tarehe 19 Machi 2020, FDA ilitoa uidhinishaji wa matumizi wa dharura (EUA) kwa Abbott Laboratories kwa kipimo cha mfumo wa Abbott wa m2000; the FDA awali ilikuwa imetoa idhini sawa na hiyo kwa Hologic, LabCorp na Thermo Fisher Scientific.